ONC offers plan for HIT safety center

The Office of the National Coordinator for Health IT has put forth a plan for developing a national Health IT Safety Center--a plan that defines the center’s focus, functions, governance and value.

The plan was developed by RTI International under contract with ONC with input from a task force of health IT safety experts, patient advocates, clinicians, vendors and healthcare organizations. "The task force did not propose for the center to have a regulatory function, but to promote health IT safety by convening interested parties, doing focused work to identify and disseminate best practices, and serve as the leading voice in addressing patient safety generally and health IT-related safety issues more specifically," wrote Andrew Gettinger, MD, ONC's chief medical information officer, in a post on the agency blog.

An “optimal” HIT Safety Center would require a funding level of $17.8 -$20.6 million over five years, according to the plan.  

"Many stakeholders are already heavily engaged in various aspects of patient safety; the center would support and complement these activities, not replace them,” states the roadmap. “The safety of health IT can be improved, and the improvement should be continuous, as part of a learning health system. To realize the proposed Center—and create a trusted space for collaborating on solutions—ONC should work with stakeholders from across the health care spectrum and government to gain support for a Health IT Safety Center based on the model described in this document.”

"Now it is up to all of us who are working for the safe and secure use of health IT to move forward to a place where clinicians are not just satisfied with their work systems but where they couldn’t possibly imagine providing clinical care without them," wrote Gettinger.

Read the roadmap.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.